Project Grant HT9425261E224
Award Date 9/30/26
Completion Date 9/29/29
Dollars Obligated $2.1M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Pasadena, CA 91125, USA
Similar Awards
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded Beckman Research Institute of The City of Hope a $416,217 Project Grant under the Military Medical Research and Development program (CFDA 12.420) for the period September 30, 2026 through September 29, 2029. The award supports research on photoacoustic computed tomography (PACT) to identify and diagnose axillary lymph nodes in breast cancer patients without requiring surgical intervention. This diagnostic imaging research...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded The Leland Stanford Junior University a Project Grant totaling $1,528,250 under the Military Medical Research and Development program (CFDA 12.420) effective May 1, 2026, with completion anticipated by April 30, 2030. The research project, titled "A Predictive Spatial Assay for Eliminating Unneeded Therapies in Primary Ductal Carcinoma in Situ," addresses breast cancer diagnostics and treatment optimization...
- Federal Project Grant Award Summary Baylor College of Medicine received a $500,000 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective June 1, 2026, through May 31, 2029. The award funds research to develop rat models of lobular carcinoma of the breast, a specialized research initiative supporting the DHA's mission to advance biomedical solutions for Service Member health and the military population. This...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded a Project Grant of $1.82M to The Leland Stanford Junior University on May 1, 2026, under the Military Medical Research and Development program (CFDA 12.420) for the development of a predictive spatial assay designed to eliminate unnecessary therapies in primary ductal carcinoma in situ (DCIS). The four-year award, with an ultimate completion date of April 30, 2030, supports research conducted at Stanford's Palo Alto,...
- Federal Project Grant Award Summary Award Overview The Defense Health Agency (DHA) awarded Dartmouth-Hitchcock Clinic a Project Grant of $5,163,060 under the Military Medical Research and Development program (CFDA 12.420) for research titled "Therapeutic Targeting of the Tumor Microenvironment in Triple-Negative Breast Cancer Patients at High Risk of Relapse and Preclinical Models of Lung Metastases." The award was issued on May 15, 2025, with a performance period extending through May...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded a $350,000 Project Grant to the University of California, Los Angeles (UCLA) on September 30, 2026, under the Military Medical Research and Development program (CFDA 12.420). The award supports the development of a polylactic acid (PLA)-based, immunohistochemistry (IHC)-compatible functional assay for detecting homologous recombination deficiency in ovarian cancer. The two-year project, scheduled for completion by...
- The U.S. Department of Defense's Defense Health Agency (DHA) awarded a $750,000 Project Grant to Stanford University to implement a spatial and single-cell multiplexed platform for the development of targeted therapies for vascularized composite allotransplantation. The funding is provided through the Military Medical Research and Development (CFDA 12.420) federal grant program, which supports advanced biomedical research to transform healthcare for military service members and the broader...
- This federal Project Grant award of $1,696,098.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) is supporting California Institute of Technology (Caltech) in conducting research on the role of the SKD3 chaperone in maintaining mitochondrial protein quality control. The award has a performance period of May 1, 2024 through April 30, 2028. This research aims to advance the understanding of mitochondrial function and protein regulation,...
- The Defense Health Agency (DHA) awarded The Leland Stanford Junior University a $7.0 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) on April 15, 2026, with a completion date of April 14, 2030. The award funds the "TAILORX Clinical Research Extension Award: Advancing Breast Cancer Treatment Stratification Through Spatial Omics and Digital Pathology," a clinical research initiative conducted at Stanford's Palo Alto, California location....
- Federal Project Grant Award Summary The University of California, San Francisco (UCSF) received a $2.72 million Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective July 15, 2025, through July 14, 2029. The award supports advanced biomedical research titled "Imaging Cardiac Metabolic Flux and Mitochondrial Function by Hyperpolarized 13C and CEST Metabolic Magnetic Resonance Imaging," which will...